ponsegromab Clinical Trials (2026): 4 Studies for Cachexia & Colorectal Cancer

Where to Participate: All ponsegromab Trial Sites in the U.S. (67 sites across 19 states)

Every actively recruiting ponsegromabtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

ponsegromab clinical trials at a glance: phase × recruitment status

Recruiting ponsegromab clinical trials (1)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

ponsegromab clinical trials by indication

ponsegromab pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Terminated and withdrawn ponsegromab trials (1)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

• NCT05492500terminatedA Study of Ponsegromab in People With Heart Failure

All ponsegromab trials (4)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

ponsegromab clinical trials: frequently asked questions

How many ponsegromab clinical trials are there?

4 ponsegromab clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 2 are marked completed.

Are ponsegromab clinical trials recruiting in 2026?

Yes — 1 ponsegromab trial is actively recruiting in 2026, with 67 U.S. sites across 19 states. See the recruiting trials and the per-state site list further down this page.

What conditions is ponsegromab being studied for?

ponsegromab is being studied for Cachexia, Colorectal Cancer, Fatigue, Healthy, Heart Failure and 4 more. The trials are grouped by indication on this page.

What phase is ponsegromab in?

ponsegromab clinical trials span 2 Phase 2, 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors ponsegromab clinical trials?

The lead sponsor across the most ponsegromab trials is Pfizer. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ponsegromabas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.